FDA Re-evaluation of Therapeutic Peptides BPC-157 KPV and Semax and the Future of Compounding Regulations
The United States Food and Drug Administration (FDA) has formally signaled a significant shift in its regulatory oversight of several…
European Medicines Agency Initiates Standardized Framework for Non-Clinical Evaluation of Microbiome-Based Medicinal Products
The European Medicines Agency (EMA), acting through its Committee for Medicinal Products for Human Use (CHMP), has formally announced the…
